| Revenue growth | Value |
|---|---|
| 1Y (TTM) | +19% |
| 3Y CAGR | +36% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | +58% |
| 3Y CAGR | +28% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
PfizerPFIZER | ₹4,627.60 -38.30 (0.82%) | 21,168.16 | 28.79 | 5.04 | ||
Caplin Point LaboratoriesCAPLIPOINT | ₹2,720.50 +9.30 (0.34%) | 20,634.90 | 30.43 | 5.75 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹6,868.00 -49.00 (0.71%) | 17,175.63 | 101.26 | 19.68 | ||
Natco PharmaNATCOPHARM | ₹843.25 -5.95 (0.70%) | 15,100.75 | 13.19 | 1.64 |